Sammy Karam is President & VP at ABBOTT LABORATORIES (ABT). They have made 5 open-market trades across 1 company since 2021, most recently 2023-02-28.
CIK 0001766718
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 38,784 | $4.5M |
Shares reported on the most recent Form 4, priced at the 2023-03-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2022-12-29 | 2023-01-03 | $108.75 | $457K | +2.3% | +1.1% | -8.5% |
| ABT | SELL | 2021-12-23 | 2021-12-28 | $140.00 | $658K | -3.5% | -14.3% | -14.6% |
| ABT | SELL | 2021-08-17 | 2021-08-19 | $125.00 | $1.0M | +0.4% | -0.8% | +2.2% |
| ABT | SELL | 2021-08-03 | 2021-08-05 | $122.50 | $980K | +3.0% | +5.2% | +5.5% |
| ABT | SELL | 2021-04-27 | 2021-04-29 | $122.00 | $1.0M | -1.8% | -12.2% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.